From vaccine hesitancy to vaccine motivation: A motivational interviewing based approach to vaccine counselling.


Journal

Human vaccines & immunotherapeutics
ISSN: 2164-554X
Titre abrégé: Hum Vaccin Immunother
Pays: United States
ID NLM: 101572652

Informations de publication

Date de publication:
31 Dec 2024
Historique:
medline: 27 8 2024
pubmed: 27 8 2024
entrez: 26 8 2024
Statut: ppublish

Résumé

The COVID-19 pandemic highlighted Vaccine Hesitancy (VH) as an accelerating global phenomenon that must be addressed. According to the WHO, thirty to fifty percent of the world's population are VH. Motivational Interviewing (MI) is an evidence-based communication style demonstrated to significantly reduce VH. MI guides people toward change through the expression of empathy and by respecting an individual's autonomy. Healthcare providers (HCPs) are the primary implementors of vaccine policies and the most trusted advisors and influencers of vaccination intention at the individual patient level. Training HCPs in MI is one of the most effective strategies to overcome VH. Many countries are currently implementing HCP training programs and population-based MI interventions to improve vaccine uptake. MI conversations are 'the heart' of vaccine decision-making processes. Understanding individual patient-level drivers of hesitancy allows clinicians to efficiently provide tailored, accurate information that reinforces a person's own motivation and confidence in their own decision. This paper describes a 4-step practical framework designed to support HCPs in their dialogue with vaccine-hesitant patients. (1)

Identifiants

pubmed: 39187772
doi: 10.1080/21645515.2024.2391625
doi:

Substances chimiques

COVID-19 Vaccines 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2391625

Auteurs

Arnaud Gagneur (A)

Department of Pediatrics, Université de Sherbrooke, Quebec, Canada.
Centre de recherche du Centre hospitalier universitaire de Sherbrooke, Quebec, Canada.

Damara Gutnick (D)

Department of Epidemiology & Population Health, The Albert Einstein College of Medicine, Bronx, NY, USA.

Patrick Berthiaume (P)

Les Formations Perspective Santé, Quebec, Canada.

Alessandro Diana (A)

IUMFE - Institute of Primary care Faculty of Medicine, University of Geneva, Geneva, Switzerland.
Paediatric Center, Grangettes Hirslanden Clinic, Geneva, Switzerland.

Stephen Rollnick (S)

Psychology, School of Medicine in Cardiff University, Wales, UK.

Prantik Saha (P)

Vagelos College of Physicians & Surgeons, Columbia University Irving Medical Center, New York, NY, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH